Paul Anthony Baguley

Title: Paul Anthony Baguley: Innovator in Pharmaceutical Chemistry

Introduction

Paul Anthony Baguley is a notable inventor based in Didcot, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic applications. With a total of 2 patents to his name, Baguley continues to push the boundaries of scientific research and innovation.

Latest Patents

Baguley's latest patents focus on a compound known as a 6-pyrimidin-isoindole derivative, which acts as an ERK1/2 inhibitor. This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide. The patent details novel physical forms of the compound, a process for preparing it, synthetic intermediates for use in the process, and novel formulations containing the compound, as well as its therapeutic uses.

Career Highlights

Paul Anthony Baguley is currently associated with Otsuka Pharmaceutical Company, Limited, where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the understanding and application of innovative compounds in medicine.

Collaborations

Throughout his career, Baguley has collaborated with esteemed colleagues, including Colin Thomas Lindley and Robert Craig Melling. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Paul Anthony Baguley stands out as a significant figure in the realm of pharmaceutical innovation. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving therapeutic options.